Insulet Corporation Cash Flow Statement
PODD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Insulet Corporation generated $569M in operating cash flow and $378M in free cash flow in FY2025. Free cash flow margin was 13.9% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $247.1M | $418.3M | $206.3M | $4.6M | $16.8M | $6.8M | $11.6M | $3.3M | -$26.8M | -$28.9M | -$73.5M | -$51.5M | -$45.0M | -$51.9M | -$45.8M |
| Depreciation & Amortization | $90.4M | $80.8M | $72.8M | $63.2M | $57.4M | $55.4M | $27.9M | $15.6M | $13.9M | $13.8M | $15.8M | $12.2M | $11.8M | $11.0M | $8.5M |
| Operating Cash Flow | $569.3M | $430.2M | $145.7M | $119.0M | -$68.1M | $84.0M | $98.4M | $35.9M | $41.3M | $15.9M | -$12.6M | $8.9M | $3.3M | -$29.1M | -$25.5M |
| Capital Expenditures | $191.6M | $124.9M | $75.6M | $122.9M | $111.9M | $129.0M | $163.7M | $157.4M | $73.8M | $22.1M | $10.6M | $11.5M | $7.3M | $11.0M | $11.1M |
| Free Cash Flow | $377.7M | $305.3M | $70.1M | -$3.9M | -$180.0M | -$45.0M | -$65.3M | -$121.5M | -$32.5M | -$6.2M | -$23.2M | -$2.6M | -$4.0M | -$40.0M | -$36.6M |
| Share Buybacks | $59.6M | $0 | $0 | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | 14.0% | 14.7% | 4.1% | -0.3% | -16.4% | -5.0% | -8.8% | -21.6% | -7.0% | -1.7% | -8.8% | -1.1% | -1.6% | -18.9% | -24.0% |